KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Humana (HUM) EBITDA Margin (2016 - 2025)

Humana has reported EBITDA Margin over the past 17 years, most recently at 2.42% for Q4 2025.

  • Quarterly results put EBITDA Margin at 2.42% for Q4 2025, up 2476.0% from a year ago — trailing twelve months through Dec 2025 was 5.86% (up 8.0% YoY), and the annual figure for FY2025 was 2.83%, down 7548.0%.
  • EBITDA Margin for Q4 2025 was 2.42% at Humana, down from 36.94% in the prior quarter.
  • Over the last five years, EBITDA Margin for HUM hit a ceiling of 192.09% in Q1 2023 and a floor of 27.19% in Q4 2024.
  • Median EBITDA Margin over the past 5 years was 6.22% (2022), compared with a mean of 35.92%.
  • Biggest five-year swings in EBITDA Margin: crashed -86991bps in 2021 and later soared 18596bps in 2023.
  • Humana's EBITDA Margin stood at 5.44% in 2021, then surged by 993bps to 48.62% in 2022, then plummeted by -101bps to 0.59% in 2023, then tumbled by -4509bps to 27.19% in 2024, then soared by 91bps to 2.42% in 2025.
  • The last three reported values for EBITDA Margin were 2.42% (Q4 2025), 36.94% (Q3 2025), and 4.21% (Q2 2025) per Business Quant data.